Targeted delivery of biodegradable nanoparticles with ultrasound-targeted microbubble destruction-mediated hVEGF-siRNA transfection in human PC-3 cells in vitro

International Journal of Molecular Medicine

Volumn 31, Issue 1, 2013, Pages 163-171

  Li, Yun Hua ^a   Shi, Qiu Sheng ^a   Du, Jing ^a   Jin, Li Fang ^a   Du, Lian Fang ^a   Liu, Pei Feng ^b   Duan, You Rong ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cyclic arginine glycine aspartic acid peptides; Gene transfection; Human PC 3 cells; Nanoparticles; Small interfering RNA; Ultrasound targeted microbubble destruction; Vascular endothelial growth factor

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; COPOLYMER; MONOMETHOXYPOLY(ETHYLENE GLYCOL) POLY(LACTIC CO GLYCOLIC ACID) POLY LYSINE TRIBLOCK COPOLYMER; NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION;

CELL LINE, TUMOR; DOWN-REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; MICROBUBBLES; NANOPARTICLES; OLIGOPEPTIDES; POLYESTERS; POLYETHYLENE GLYCOLS; RNA, SMALL INTERFERING; TRANSFECTION; ULTRASONICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873109027     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1175     Document Type: Article

References (36)

1. Namiecińska M, Marciniak K and Nowak JZ: VEGF as an angiogenic, neurotrophic, and neuroprotective factor. Postepy Hig Med Dosw (Online) 59: 573-583, 2005 (In Polish).
2. Anai S, Sakamoto N, Sakai Y, Tanaka M, Porvasnik S, Urbanek C, Cao W, Goodison S and Rosser CJ: Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer. Urol Oncol 29: 421-429, 2011.
3. Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP and Shen GX: Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Br J Dermatol 153: 715-724, 2005.
4. Rhee J and Hoff PM: Angiogenesis inhibitors in the treatment of cancer. Expert Opin Pharmacother 6: 1701-1711, 2005.
5. Sitohy B, Nagy JA and Dvorak HF: Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res 72: 1909-1914, 2012.
6. Chakraborty C: Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing. Curr Drug Targets 8: 469-482, 2007.
7. McNamara JO II, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA and Giangrande PH: Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24: 1005-1015, 2006.
8. Du J, Sun Y, Shi QS, Liu PF, Zhu MJ, Wang CH, Du LF and Duan YR: Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing. Int J Mol Sci 13: 516-533, 2012.
9. Vamer JA and Cheresh DA: Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv Oncol 1: 69-87, 1996.
10. Eliceiri BP and Cheresh DA: The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 103: 1227-1230, 1999.
11. Zheng DQ, Woodard AS, Fornaro M, Tallini G and Languino LR: Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 59: 1655-1664, 1999.
12. Li HL, Zheng XZ, Wang HP, Li F, Wu Y and Du LF: Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther 16: 1146-1153, 2009.
13. Carson AR, McTiernan CF, Lavery L, Hodnick A, Grata M, Leng X, Wang J, Chen X, Modzelewski RA and Villanueva FS: Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 37: 393-402, 2011.
14. Shohet RV and Grayburn PA: Potential bioeffects of ultrasonic destruction of microbubble contrast agents. J Am Coll Cardiol 47: 1469-1470, 2006.
15. Lai CY, Wu CH, Chen CC and Li PC: Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability. Ultrasound Med Biol 32: 1931-1941, 2006.
16. Ay T, Havaux X, Van Camp G, Campanelli B, Gisellu G, Pasque A, Denef JF, Melin JA and Vanoverschelde JL: Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure and microvascular integrity. Circulation 104: 461-466, 2001.
17. Xie J, Shen Z, Li KC and Danthi N: Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle. Int J Nanomedicine 2: 479-485, 2007.
18. Lin RY, Dayananda K, Chen TJ, Chen CY, Liu GC, Lin KL and Wang YM: Targeted RGD nanoparticles for highly sensitive in vivo integrin receptor imaging. Contrast Media Mol Imaging 7: 7-18, 2012.
19. Mu Y, Li L and Ayoufu G: Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS. Ultrasonics 49: 676-681, 2009.
20. Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, Matsunaga TO and Ferrara KW: Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 3: 125-134, 2004.
21. Rong W, Wang J, Liu X, Jiang L, Wei F, Hu X, Han X and Liu Z: Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury. Neurochem Res 37: 1615-1623, 2012.
22. Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC and Mignatti P: VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 103: 17260-17265, 2006.
23. Fadok VA, Bratton DL, Frasch SC, Warner ML and Henson PM: The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5: 551-562, 1998.
24. Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G, Tang J and Ma D: TFAR19, a novel apoptosis-related gene,cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254: 203-210, 1999.
25. Xu L, Chen Y, Song Q, Xu D, Wang Y and Ma D: PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 11: 345-354, 2009.
26. Zhuge C, Chang Y, Li Y, Chen Y and Lei J: PDCD5-regulated cell fate decision after ultraviolet-irradiation-induced DNA damage. Biophys J 101: 2582-2591, 2011.
27. Chen Y, Sun R, Han W, Zhang Y, Song Q, Di C and Ma D: Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509: 191-196, 2001.
28. Jiang J, Wang N, Guan Z and Houshan LV: Programmed cell death 5 factor enhances triptolide-induced fibroblast-like synoviocyte apoptosis of rheumatoid arthritis. Artif Cells Blood Substit Immobil Biotechnol 38: 38-42, 2010.
29. Wang Y, Li X, Wang L, Ding P, Zhang Y, Han W and Ma D: An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117: 1525-1532, 2004.
30. Feril LB Jr, Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S and Nakamura S: Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29: 331-337, 2003.
31. Honda H, Zhao QL and Kondo T: Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 28: 673-682, 2002.
32. Skyba DM, Price RJ, Linka AZ, Skalak TC and Kaul S: Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 98: 290-293, 1998.
33. Miller MW, Everbach EC, Cox C, Knapp RR, Brayman AA and Sherman TA: A comparison of hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations. Ultrasound Med Biol 27: 709-721, 2001.
34. Danhier F, Pourcelle V, Marchand-Brynaert J, Jérôme C, Feron O and Préat V: Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles. Methods Enzymol 508: 157-175, 2012.
35. Liu P, Qi X, Sun Y, Wang H, Li Y and Duan Y: RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts in vivo. J Nanosci Nanotechnol 11: 10760-10764, 2011.
36. Karshafian R, Samac S, Bevan PD and Burns PN: Microbubble mediated sonoporation of cells in suspension: clonogenic viability and influence of molecular size on uptake. Ultrasonics 50: 691-697, 2010.